A detailed history of Center Book Partners LP transactions in Liquidia Corp stock. As of the latest transaction made, Center Book Partners LP holds 1,103,850 shares of LQDA stock, worth $26.6 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
1,103,850
Previous 121,072 811.73%
Holding current value
$26.6 Million
Previous $1.79 Million 670.48%
% of portfolio
0.81%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$11.99 - $19.3 $11.8 Million - $19 Million
982,778 Added 811.73%
1,103,850 $13.8 Million
Q1 2025

May 09, 2025

BUY
$11.36 - $16.5 $1.38 Million - $2 Million
121,072 New
121,072 $1.79 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.55B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.